A quantitative assessment of Staphylococcus aureus community carriage in Yuma, Arizona - Russakoff, Benjamin; Wood, Colin; Lininger, Monica R.; Barger, Steven D.; Trotter, Robert T.; Maltinsky, Sara; Mbegbu, Mimi; Coyne, Briana; Yague, David Panisello; Kyman, Shari; Tucker-Morgan, Kara; Ceniceros, Kathya; et al. (medRxiv, 2022)
Staphylococcus aureus is a frequent cause of mild and severe infections that occur when these commensal bacteria penetrate the outer layers of skin or mucosa. As most S. aureus infections are the result of autoinfection, and community-acquired infections are increasingly common, it is important to better understand S. aureus colonization characteristics in the community setting. Using standard culture technique and a quantitative PCR assay (SaQuant), we detected and quantified S. aureus across the nares, throat, and palm of 548 community-dwelling individuals in southwestern Arizona. Using culture-based methods, we detected S. aureus colonization in the nares of 26.3% of individuals (n = 144); however, the combination of two detection methods across multiple body sites resulted in much higher prevalence than has been reported previously. Overall, 65.9% of participants were colonized, with significantly higher prevalence in males (compared to females) and non-Hispanics (compared to Hispanics), with this pattern especially evident in nares and throat samples. Colonizing quantities in the nares were slightly higher in males and significantly greater among non-Hispanics. The clear sex and ethnicity patterns warrant further investigation in order to identify and leverage protective factors that may drive these disparities. In the nares, S. aureus density was the highest, most variable, and correlates with colonization in other body sites such as throat and palm. Our results demonstrate that screening by culture-based methods only can miss individuals colonized by S. aureus and that previous carriage statistics are likely underestimates. By including a highly sensitive quantitative assay, this work provides a roadmap towards more comprehensive and accurate characterization of S. aureus carriage and the potential for more effective mitigation.AUTHOR SUMMARY Effective disease control and prevention is tied to pathogen identification and understanding reservoirs. Staphylococcus aureus infection prevention efforts and protocols are based upon decades of research on colonization patterns and associated links to subsequent infection. Unfortunately, efforts to prevent S. aureus infections have been met with diminishing returns, suggesting significant gaps in fundamental knowledge of colonization. However, this knowledge and resulting protocols, are founded upon culture-based detection. By employing a new quantitative PCR assay on samples from three body sites in 548 individuals, we can characterize colonization more comprehensively than previous studies by describing both prevalence and pathogen quantity. Our highly sensitive detection resulted in an overall prevalence of 65.9%. Higher quantities were associated with the nares and were highest among non-Hispanic males (86.9%). Overall prevalence was much higher than has been previously documented. Common research practices, such as culture-based detection from a single body site, may misclassify over half of colonized persons. Future studies incorporating quantitative data, especially with longitudinal sampling at more body sites will provide a more wholistic understanding of community carriage, colonization dynamics, and likelihood of autoinfection and transmission.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the NAU Southwest Health Equity Research Collaborative, which is funded by the National Institute on Minority Health and Health Disparities at the National Institutes of Health (U54MD012388). Funding was also received from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (R15AI156771). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Northern Arizona University Institutional Review Board.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript